Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-342,200
Closed -$16.5M 189
2025
Q2
$16.5M Sell
342,200
-19,400
-5% -$991K 0.36% 62
2025
Q1
$20.1M Sell
361,600
-126,700
-26% -$6.86M 0.38% 52
2024
Q4
$23.6M Buy
488,300
+85,800
+21% +$4.36M 0.41% 47
2024
Q3
$23.2M Buy
402,500
+175,920
+78% +$9.5M 0.42% 48
2024
Q2
$11M Sell
226,580
-422,000
-65% -$20.4M 0.2% 75
2024
Q1
$31.5M Buy
648,580
+34,800
+6% +$1.7M 0.67% 35
2023
Q4
$30.5M Buy
613,780
+105,775
+21% +$5.17M 1.12% 23
2023
Q3
$27.2M Buy
508,005
+348,125
+218% +$18.6M 0.7% 32
2023
Q2
$8.62M Buy
+159,880
New +$8.6M 0.2% 66

Other funds holding SNY

Zimmer Partners's SNY Position: Q3 2025 in Review

Zimmer Partners sold out of Sanofi (SNY) in Q3 2025, closing a stake of 342,200 shares — an estimated $16.5M sold.

Zimmer Partners first reported a position in SNY in Q2 2023 and held it in 9 quarters. The position peaked at $31.5M in Q1 2024. 712 funds tracked by Wall St. Rank hold SNY as of Q3 2025.

  • Zimmer Partners reported no remaining Sanofi position as of Q3 2025 after selling out during the quarter.
  • Zimmer Partners sold 342,200 Sanofi shares in Q3 2025, an estimated $16.5M.
  • Zimmer Partners first reported a position in Sanofi in Q2 2023 and held it in 9 quarters.
  • Zimmer Partners's Sanofi position peaked at $31.5M in Q1 2024.
  • 712 funds tracked by Wall St. Rank held Sanofi as of Q3 2025.

Based on Zimmer Partners's 13F filing for Q3 2025, filed 14 Nov 2025.